Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT04903132
The purpose of this study is to test if senescent cells and their secretome contribute to Long-Hauler Syndrome and if a clinical trial of senolytic drugs, which selectively eliminate senescent cells, should be initiated.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Observational
Rochester, Minnesota, 55905, United States
Assays for cellular senescence markers, SASP factors, inflammatory mediators, pro-fibrotic factors, and auto-antibodies in blood and urine will be conducted in patients who provide informed consent. Data will be related to subject age, date of COVID-19 infection, severity of that infection, current Long-Hauler Syndrome symptoms), physical examination findings, underlying conditions, and laboratory data. To understand if an association between features of Long-Hauler Syndrome with markers of cellular senescence and SASP factors can be demonstrated, or SASP factors are higher in Long-Hauler Syndrome clinic patients than controls in this pilot study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Longhauler's Cohort -
Inclusion criteria
Exclusion criteria
Control Cohort -
Inclusion criteria
Exclusion criteria
COVID-19 Control Cohort
Inclusion criteria
Exclusion criteria
Time frame: 6 months
If a correlation between features of Long-Hauler Syndrome with markers of cellular senescence and SASP factors can be demonstrated, or SASP factors are higher in Long-Hauler Syndrome clinic patients than age- and sex-matched controls (using archived samples) in this pilot study, a protocol will be submitted to the IRB for a trial in Long-Hauler Syndrome patients of senolytic drugs.
Mayo Clinic
Other
Cellular Senescence and Its Contribution to COVID-19 Long-Hauler Syndrome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05852873
COVID-19, Coronaviridae Infections
Bergen, Vestland, Norway
View Trial DetailsNCT04830852
COVID-19, Coronaviridae Infections
Washington D.C., District of Columbia, United States
View Trial DetailsNCT05125887
COVID-19, Coronaviridae Infections
Limoges, France
View Trial DetailsNCT04590222
COVID-19, Coronaviridae Infections
Le Kremlin-Bicêtre, France
View Trial Details